Vixarelimab
Systemic Sclerosis With Lung Involvement
Genentech, Inc.Phase 2
—
Rating in progress
Vixarelimab in Systemic Sclerosis With Lung Involvement is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active